These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7037067)

  • 1. Differential role of fractionated heparin in antithrombin-III proteolysis.
    Marciniak E
    Blood; 1982 Mar; 59(3):576-81. PubMed ID: 7037067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement by heparin of thrombin-induced antithrombin III proteolysis: its relation to the molecular weight and anticoagulant activity of heparin.
    Marciniak E; Gora-Maslak G
    Thromb Res; 1982 Nov; 28(3):411-21. PubMed ID: 7179225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E
    Br J Haematol; 1981 Jun; 48(2):325-36. PubMed ID: 7236529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of immobilized thrombin with human antithrombin III.
    Marciniak E; Gora-Maslak G
    Thromb Haemost; 1984 Feb; 51(1):27-31. PubMed ID: 6719385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity-purified heparin.
    Nesheim M; Blackburn MN; Lawler CM; Mann KG
    J Biol Chem; 1986 Mar; 261(7):3214-21. PubMed ID: 3949769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of alpha-thrombin.
    Olson ST
    J Biol Chem; 1985 Aug; 260(18):10153-60. PubMed ID: 4019506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependence of the rate of thrombin/antithrombin III reaction upon the turnover rate of a catalytic amount of heparin.
    Oshima G
    Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2155-9. PubMed ID: 2598315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
    Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
    Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
    Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
    J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of heparin with the human plasma heparin-binding proteins thrombin, antithrombin III, and apolipoproteins E and B-100.
    Cardin AD; Barnhart RL; Witt KR; Jackson RL
    Thromb Res; 1984 Jun; 34(6):541-50. PubMed ID: 6740570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin.
    Kress LF; Catanese J
    Biochim Biophys Acta; 1980 Sep; 615(1):178-86. PubMed ID: 7426659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of heparin on thrombin-antithrombin reaction.
    Machovich R; Blaskó G; Pálos LA
    Biochim Biophys Acta; 1975 Jan; 379(1):193-200. PubMed ID: 1115795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory activities for thrombin and factor Xa of whale heparin: comparative studies on two preparations from different species.
    Ototani N; Yosizawa Z
    Tohoku J Exp Med; 1986 Sep; 150(1):77-82. PubMed ID: 3775773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric distribution of sites with high affinity for antithrombin III in rat skin heparin proteoglycans.
    Horner AA; Young E
    J Biol Chem; 1982 Aug; 257(15):8749-54. PubMed ID: 7096332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin BM from human plasma: an antithrombin binding moderately to heparin.
    Wunderwald P; Schrenk WJ; Port H
    Thromb Res; 1982 Feb; 25(3):177-91. PubMed ID: 6175043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavior of antithrombin III isoforms on immobilized heparins. Evidence that the isoforms bind to different numbers of low-affinity heparin sites.
    Carlson TH; Babcock T; Atencio AC; Levinson C; Mora HR
    J Biol Chem; 1988 Feb; 263(5):2187-94. PubMed ID: 3339006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against antithrombin III. Identification of their epitopes and effects on antithrombin III activities.
    Knoller S; Savion N
    Eur J Biochem; 1989 Mar; 180(2):319-26. PubMed ID: 2466666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.